Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2025-12-25 @ 7:25 PM
NCT ID:
NCT02846532
Group ID:
EG000
Title:
Rivaroxaban (Part A)
Description:
Participants received rivaroxaban as 0.1 percent (%) (1 milligram per milliliter \[mg/ml\]) oral suspension with target exposure matching to that of rivaroxaban 10 mg given once daily in adults as per participant's body weight adjusted total daily dosing administered as two doses 12 hours apart (7 to less than \[\<\] 8 kilograms \[kg\] participant received 2.2 mg; 8 to \<10 kg received 3.2 mg; 10 to \<12 kg received 3.4 mg; 12 to \<20 kg received 4.0 mg; and 20 to \<30 kg received 5.0 mg) (morning and evening dosing), up to 12 months.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
12
Other Number Affected:
11
Other Number At Risk:
12
Study:
NCT02846532
Results Section:
NCT02846532
Adverse Events Module:
NCT02846532